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Conditional inactivation of Akt three
isoforms causes tau hyperphosphorylation
in the brain
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Abstract
Background: Tau hyperphosphorylation plays a critical role in neurodegenerative diseases [EMBO Mol Med. 6:1142-60,
2014; Annu Rev Neurosci. 24:1121-59, 2001]. Recent evidence has shown that Akt is down-regulated in AD [J Pathol.
225:54-62, 2011]. However, it remained unknown which pathological process, e.g. tau pathology or neuron death, Akt
may contribute to. In this study, Cre-loxP technique was employed to generate a viable Akt three isoforms conditional
knockout (Akt cTKO) mouse in which total Akt levels were dramatically reduced in the adult brain.
Results: Significantly increased levels of tau phosphorylated (p-tau) at various sites were observed in Akt cTKO mice as
compared to age-matched littermate controls. Increased levels for phosphorylated GSK3α and phosphorylated PKA
substrates were detected in Akt cTKO brains. In contrast, no significant changes on p-tau levels were found in Akt1−/−,
Akt2−/− or Akt3−/− mice.
Conclusions: Akt may regulate tau phosphorylation in the adult brain by affecting activities for PKA and GSK3α.
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Findings
Mice with global deletion of Akt three isoforms (Akt TKO
or Akt1−/−;Akt2−/−;Akt3−/−) were early embryonic lethal
[1], precluding the possibility to study its in vivo function.
To obtain viable Akt conditional TKO (cTKO) mouse, we
generated floxed Akt1 (Additional file 1: Figure S1A).
After several steps of crossing, Akt1f/f;Akt2−/−;Akt3
−/−;CAG-CreER mice were obtained and became Akt
cTKO after the treatment with tamoxifen. To examine
Cre-mediated recombination efficiency in the brain,
biochemical analyses were conducted. Dramatic reduc-
tion on levels for total Akt (t-Akt) was observed in the
brain of cTKO mice (Additional file 1: Figure S1B).
Levels of p-AktSer473, an activated form of Akt, were
markedly decreased in Akt cTKO (Additional file 1:
Figure S1B). Immunohistochemistry (IHC) results
showed very weak immuno-reactivity of t-Akt in the brain
of Akt cTKO mice (Additional file 1: Figure S1C-d-f, a-c
for controls).
Increased levels of tau phosphorylated (p-tau) at the
Thr205, Thr231 and Ser396 epitopes have been widely
reported in Alzheimer’s brain and mouse models [2].
Our Western results showed highly increased levels for
p-tauT205, p-tauT231 and p-tauS396 in Akt cTKO mice
(Fig. 1a). Moreover, the position of p-tau bands at the
60, 64 and 68 kDa in the SDS gels was consistently
higher in Akt cTKOs than that in controls (Fig. 1a),
likely due to the slow migrating rate caused by tau
hyperphosphorylation. We conducted additional control
experiments and used two groups of Akt2/3 double KO
mice, Akt1f/f;Akt2−/−;Akt3−/−;CAG-CreER and Akt1f/
f;Akt2−/−;Akt3−/−, which were age- matched littermates
to Akt cTKOs. We found that Akt DKO mice did not
show significant changes on p-tau levels (Additional file
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1: Figure S2). Strong p-tauThr205 immuno-reactivity was
clearly seen in the cytoplasm of neurons in various brain
sub-areas of Akt cTKOs but not controls (Fig. 1b). In-
creased p-tauSer396 immuno-reactivity was largely de-
tected in glial-like cells in the brain of Akt cTKOs
(Additional file 1: Figure S3). Immunostaining on p-
tauThr231 showed strong signals in neuronal branches of
the cTKO mice (Additional file 1: Figure S4), and double-
staining with MAP2 suggested dendritic localization for p-
tauThr231 (Additional file 1: Figure S4C: a-d).
TUNEL assay was performed to examine cell death.
No difference in the total number of TUNEL+ cells was
observed in brains of Akt cTKO and control mice
(Additional file 1: Figure S5), suggesting no significant
change in apoptosis. Markers for neurons, astrocytes
and microglia were used for biochemical and morpho-
logical analyses. First, there was no significant reduc-
tion on cortical levels for NeuN, GFAP and Iba1 in Akt
cTKO mice (Additional file 1: Figure S6A). Second,
there was comparable immuno-reactivity for NeuN, GFAP
or Iba1 (Additional file 1: Figure S6B-C) in control and
Akt cTKO mice. Therefore, deletion of Akt does not sig-
nificantly affect the survival of cortical cells.
To determine the role of Akt single isoform in tau
phosphorylation in the brain, we analyzed p-tau levels
using cortical lysates from three lines of Akt single
isoform KO mice including Akt1−/− [3], Akt2−/− [4] and
Akt3−/− [5]. Nissl staining revealed comparable brain
structure between Akt1−/−, Akt2−/−, Akt3−/− and their
age-matched WT littermates (Fig. 2). Consistent with previ-
ously published observations [5, 6], Akt3−/− mice displayed
smaller brain than WT (Fig. 2e). However, no significant
changes in p-tau levels were observed in Akt1−/−, Akt2−/−
and Akt3−/− mice (Fig. 2b,d,f: ps > 0.05), suggesting that tau
hyperphosphorylation shown in Akt cTKO mice is unlikely
to be caused by loss of a single Akt isoform.
To dissect molecular pathways involved, we conducted
Western blotting using an antibody against phosphory-
lated Akt substrates. We found increased intensities for
several bands including those for GSK3α/3β in Akt
cTKO mice (Additional file 1: Figure S7A). Since GSK3
is a substrate of Akt, it is expected that deletion of Akt may
cause reduced levels for phosphorylated GSK3α/3β [7].
However, we found that relative levels for p-GSK3βSer9
were significantly increased in Akt cTKO mice (Additional
file 1: Figure S7B) and those for p-GSK3αTyr279 were also
Fig. 1 Tau hyperphosphorylation in the brain of Akt cTKO mice. a Western blotting of p-tau using cortical and cerebellar samples. Antibodies
against tau phosphorylated at the Thr205, Thr231 and Ser396 epitopes were used. The migration of three p-tau bands (60 kDa, 64 kDa and
68 kDa) in SDS gels was slower in Akt cTKO (Akt1f/f;Akt2−/−;Akt3−/−;CAG-CreER with tamoxifen treatment) than in control mice (Akt1f/f;Akt2+/+;Akt3+/+
and Akt1f/+;Akt2+/+;Akt3+/+). Intensities of the p-tau bands were dramatically increased in Akt cTKO mice. Tau5 antibody was used to detect total
tau (t-tau). b Immunohistochemistry of p-tauThr205 in the brain. Strong immuno-reactivity of p-tauThr205 was seen in the cortex (e), hippocampal
CA3 (f), the hilus of the dentate gyrus (g) and the cerebellum (h) of Akt cTKO mice. Weak immuno-reactivity of p-tauThr205 was observed in different
brain sub-areas of control mice (a-d)
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increased (Fig. 3a), suggesting inhibition of GSK3β but acti-
vation of GSK3α. Since β-catenin is a well-known substrate
of GSK3 [8, 9], p-β-cateninSer33/Ser37/Thr41 was examined
and showed significantly increased levels in Akt cTKOs
(Additional file 1: Figure S7C), suggesting elevated GSK3α
activity. Moreover, we examined several other tau kinases.
First, although levels for p-Cdk5Ser159 were increased, those
for p25 were decreased (Fig. 3b, p < 0.05). Second, no sig-
nificant changes on levels for p-Erk1/2 and p-p38 were de-
tected in Akt cTKO mice (Fig. 3c-d, ps > 0.05). Overall,
activities for GSK3β, Cdk5, Erk and MAPK p38 were
not enhanced.
Fig. 2 Unchanged levels of p-tau in Akt single isoform KO mice. a Nissl staining for the brain of Akt1−/− mice. Normal brain structure was
observed. b Western analyses on p-tau levels using cortical samples of Akt1−/− mice. There was no significant difference on relative levels of
p-tauThr205, p-tauThr231 and p-tauSer396 in Akt1−/− mice. c Nissl staining for the brain of Akt2−/− mice. No abnormal brain structure was detected.
d Western analyses on p-tau levels using cortical samples of Akt2−/− mice revealed no significant difference. e Nissl staining for the brain of
Akt3−/− mice. There was a smaller brain in Akt3−/− mice than in WT animals. f Western analyses on p-tau levels showed no significant difference
in Akt3−/− mice (NS = not significant)
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It has been shown that GSK3β is phosphorylated at
the Ser9 site not only by Akt but also by PKA [10]. The
tyrosine phosphorylation of GSK3 requires the cAMP-
PKA signaling [11, 12]. Moreover, it is known that PKA
is a kinase to phosphorylate tau at the sites of Thr205,
Thr231 and Ser396 [2, 13]. To test the possibility that
PKA is involved, we performed the following experi-
ments. First, an antibody against phosphorylated PKA
substrates was used to conduct Western blotting. In-
creased levels for several bands with a wide range of
molecular weights were observed (Fig. 4a), suggesting
increased PKA activity. Second, we examined VASP, a
well-known PKA substrate [14, 15], and observed
highly increased p-VASPSer157 levels (Fig. 4b). In con-
trast, expression levels of PKA regulatory subunits, 1α
and 1β, were unchanged (Fig. 4b). Third, since the
Ser214 [16] and Ser356 [17, 18] sites of tau are phos-
phorylated by PKA as well, we analyzed p-tauSer214 and
p-tauSer356, which exhibited increased levels in Akt
cTKO mice (Fig. 4c).
Discussion
Akt levels are decreased in Alzheimer’s brain [19]. How-
ever, it remains unknown exactly how Akt is involved in
pathophysiological processes of AD, e.g. tau pathology
and neurodegeneration. In this study, a novel Akt cTKO
mouse model was generated and displayed tau hyper-
phosphorylation in the brain. We demonstrated that Akt
cTKO mice exhibited significantly increased levels for
several PKA downstream substrates. We observed in-
creased levels for an activated form of GSK3α in Akt
cTKO mice. We reported unchanged levels for activated
forms of GSK3β, Cdk5, Erk and MAPK p38 in Akt
cTKO mice.
It had been difficult to study normal physiological
functions of Akt in the adult brain. First, while there are
Fig. 3 Increased levels for an activated form of GSK3α in the brain of Akt cTKO mice. a Western blotting on activated forms of GSK3α and GSK3β.
Quantitative analysis showed significantly increased levels for p-GSK3αTyr279 (*, p < 0.05) but unchanged levels for p-GSK3βTyr216 (NS, p > 0.05) in
Akt cTKO mice. b Western blotting on p-Cdk5, p35 and p25. Relative levels for p-Cdk5Ser159 were significantly increased (*, p < 0.05), but those for
p25 were significantly decreased (*, p < 0.05) in the cortex of Akt cTKO mice. GAPDH served as the loading control. c Western blotting on MAPK
Erk1/2. Total Erk1/2 levels in Akt cTKO mice were not different from those in control mice. β-actin served as the loading control. Ratio of p-Erk1/2
to the total Erk1/2 in Akt cTKO mice was also not different from that in control mice (p > 0.05). d Western blotting on phosphorylated MAPK p38
(p-p38). Levels of total p38 did not differ between Akt cTKO and control mice (p > 0.05). Ratio of p-p38 to total p38 in Akt cTKO mice was not
changed (NS = not significant)
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three Akt isoforms in mammals [20], a recent study did
not identify which Akt isoform plays important role in
neurodegenerative disease [19]. Second, since global de-
letion of Akt three isoforms causes early embryonic
death in mice [1], a viable Akt cTKO mouse model was
generated to overcome developmental problems in this
study. Interestingly, Akt cTKO animals but not Akt sin-
gle isoform KO mice exhibited increased p-tau levels in
the brain, suggesting that total Akt but not a single iso-
form plays a key role in tau phosphorylation. Immuno-
staining using AT8 or AT100 antibodies revealed no
NFTs-like structure in Akt cTKO mice (data not shown).
No significant changes on the total number of TUNEL+
cells or NeuN+ cells were detected in Akt cTKO mice.
These findings are consistent with the concept that tau
hyperphosphorylation is an early event during neurode-
generative process [21].
Tau phosphorylation status is determined by activities
of multiple protein kinases [22]. Since there were un-
changed levels for activated forms of GSK3β, Cdk5, Erk
and p38, it is unlikely that they could account for abnor-
mal tau phosphorylation in Akt cTKO mice. Although it
is believed that inactivation of Akt may cause reduced p-
GSK3αS21/3βS9 [7] and thus lifts the inhibition on GSK3,
levels for p-GSK3βS9 were actually increased in Akt
cTKO mice. Since GSK3β is a substrate for both Akt
and PKA [10, 12], in the absence of Akt, it can be phos-
phorylated by PKA. The findings on phosphorylated
PKA substrates, p-VASP and p-tau (Fig. 4) suggest en-
hanced PKA activity, which helps explain why there was
tau hyperphosphorylation in Akt cTKO mice. There are
two possible mechanisms by which Akt regulates PKA
activity. The first possibility is a compensatory mechan-
ism. It is known that the PI3K-Akt [23] and PKA pathways
[24] can be activated by extracellular signal molecules such
as cytokines. In the absence of the PI3K-Akt pathway, such
molecules may over-activate the cAMP-PKA signaling as
compensation. The second mechanism is that phosphodies-
terases (PDEs) might be involved in the regulation of PAK
activity. PDEs are Akt substrates [25] and can degrade
cAMP, the second messenger molecule [26]. Therefore, de-
letion of Akt may inhibit PDEs and cAMP levels may get
increased. Upon activation by cAMP, PKA can act on vari-
ous downstream targets including tau, GSK3 and VASP.
Methods
Generation of Akt1f/f and Akt cTKO mice
We used a strategy shown in Additional file 1: Figure
S1A to generate floxed Akt1 mice. The detailed breeding
plan for the generation of Akt cTKO mice was described
in the Additional file 1.
Treatment of mice with tamoxifen
Tamoxifen was used to treat Akt1f/f;Akt2−/−;Akt3
−/−;CAG-CreER and age-matched littermate controls for
5 consecutive days. Detailed information was described
in the Additional file 1.
Brain lysates preparation
Procedures were described previously [27]. Immunoblot-
ting methods and antibody information were described
in the Additional file 1.
Fig. 4 Increased levels for phosphorylated PKA substrates in Akt cTKO mice. a Western blotting for phosphorylated PKA substrates using cortical
samples of Akt cTKO mice. Levels for several phosphorylated PKA substrates with molecular weights at about 100 kDa, 60 kDa and 40 kDa
were increased. b Western analyses on VASP and PKA subunits. P-VASPSer157 levels in Akt cTKO mice were highly increased but total VASP
levels were not changed. Relative levels for PKA regulatory subunits, 1α and 1β, were not changed. GAPDH served as the loading control.
c Western blotting on p-tauSer214 and p-tauSer356. Ratios of p-tau to total tau were significantly increased in Akt cTKO mice, as compared to control
animals (*, p < 0.05)
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Statistical analysis
Data were presented as the mean ± SEM. Two-tailed
Student’s t-test was performed to examine the difference
between control and cKO mice. P < 0.05 (*) was consid-
ered statistically significant.
Ethical approval
Mouse breeding was conducted under IACUC approved
protocols at the MARC (Model Animal Research Cen-
ter). All the experiments were performed in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals of the MARC at Nanjing University.
Additional file
Additional file 1: Conditional inactivation of Akt three isoforms
causes tau hyperphosphorylation in the brain. (PDF 3519 kb)
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